Share-based Payment Arrangement, Expense of SELLAS Life Sciences Group, Inc. from 31 Dec 2011 to 30 Sep 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
SELLAS Life Sciences Group, Inc. quarterly and annual Share-based Payment Arrangement, Expense in USD history and change rate from 31 Dec 2011 to 30 Sep 2025.
  • SELLAS Life Sciences Group, Inc. Share-based Payment Arrangement, Expense for the quarter ending 30 Sep 2025 was $503,000, a 32% increase year-over-year.
  • SELLAS Life Sciences Group, Inc. Share-based Payment Arrangement, Expense for the twelve months ending 30 Sep 2025 was $1,882,000, a 11% increase year-over-year.
  • SELLAS Life Sciences Group, Inc. annual Share-based Payment Arrangement, Expense for 2024 was $1,564,000, a 25% decline from 2023.
  • SELLAS Life Sciences Group, Inc. annual Share-based Payment Arrangement, Expense for 2023 was $2,094,000, a 21% increase from 2022.
  • SELLAS Life Sciences Group, Inc. annual Share-based Payment Arrangement, Expense for 2022 was $1,726,000, a 71% increase from 2021.
Source SEC data
View on sec.gov
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Quarterly (USD)
Share-based Payment Arrangement, Expense, YoY Quarterly Change (%)
Share-based Payment Arrangement, Expense, Annual (USD)
Share-based Payment Arrangement, Expense, YoY Annual Change (%)

SELLAS Life Sciences Group, Inc. Quarterly Share-based Payment Arrangement, Expense (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q3 2025 $1,882,000 $503,000 +$122,000 +32% 01 Jul 2025 30 Sep 2025 10-Q 12 Nov 2025 2025 Q3
Q2 2025 $1,760,000 $501,000 +$167,000 +50% 01 Apr 2025 30 Jun 2025 10-Q 12 Aug 2025 2025 Q2
Q1 2025 $1,593,000 $505,000 +$29,000 +6.1% 01 Jan 2025 31 Mar 2025 10-Q 13 May 2025 2025 Q1
Q4 2024 $1,564,000 $373,000 -$124,000 -25% 01 Oct 2024 31 Dec 2024 10-K 20 Mar 2025 2024 FY
Q3 2024 $1,688,000 $381,000 -$162,000 -30% 01 Jul 2024 30 Sep 2024 10-Q 12 Nov 2025 2025 Q3
Q2 2024 $1,850,000 $334,000 -$180,000 -35% 01 Apr 2024 30 Jun 2024 10-Q 12 Aug 2025 2025 Q2
Q1 2024 $2,030,000 $476,000 -$64,000 -12% 01 Jan 2024 31 Mar 2024 10-Q 13 May 2025 2025 Q1
Q4 2023 $2,094,000 $497,000 +$51,000 +11% 01 Oct 2023 31 Dec 2023 10-K 20 Mar 2025 2024 FY
Q3 2023 $2,043,000 $543,000 +$88,000 +19% 01 Jul 2023 30 Sep 2023 10-Q 13 Nov 2024 2024 Q3
Q2 2023 $1,955,000 $514,000 +$64,000 +14% 01 Apr 2023 30 Jun 2023 10-Q 13 Aug 2024 2024 Q2
Q1 2023 $1,891,000 $540,000 +$165,000 +44% 01 Jan 2023 31 Mar 2023 10-Q 14 May 2024 2024 Q1
Q4 2022 $1,726,000 $446,000 +$158,000 +55% 01 Oct 2022 31 Dec 2022 10-K 28 Mar 2024 2023 FY
Q3 2022 $1,568,000 $455,000 +$180,000 +65% 01 Jul 2022 30 Sep 2022 10-Q 09 Nov 2023 2023 Q3
Q2 2022 $1,388,000 $450,000 +$186,000 +70% 01 Apr 2022 30 Jun 2022 10-Q 10 Aug 2023 2023 Q2
Q1 2022 $1,202,000 $375,000 +$191,000 +104% 01 Jan 2022 31 Mar 2022 10-Q 11 May 2023 2023 Q1
Q4 2021 $1,011,000 $288,000 +$147,000 +104% 01 Oct 2021 31 Dec 2021 10-K 16 Mar 2023 2022 FY
Q3 2021 $864,000 $275,000 +$129,000 +88% 01 Jul 2021 30 Sep 2021 10-Q 14 Nov 2022 2022 Q3
Q2 2021 $735,000 $264,000 +$118,000 +81% 01 Apr 2021 30 Jun 2021 10-Q 11 Aug 2022 2022 Q2
Q1 2021 $617,000 $184,000 +$39,000 +27% 01 Jan 2021 31 Mar 2021 10-Q 12 May 2022 2022 Q1
Q4 2020 $578,000 $141,000 -$6,000 -4.1% 01 Oct 2020 31 Dec 2020 10-K 31 Mar 2022 2021 FY
Q3 2020 $584,000 $146,000 +$31,000 +27% 01 Jul 2020 30 Sep 2020 10-Q 12 Nov 2021 2021 Q3
Q2 2020 $553,000 $146,000 +$20,000 +16% 01 Apr 2020 30 Jun 2020 10-Q 12 Aug 2021 2021 Q2
Q1 2020 $533,000 $145,000 -$40,000 -22% 01 Jan 2020 31 Mar 2020 10-Q 13 May 2021 2021 Q1
Q4 2019 $573,000 $147,000 +$35,000 +31% 01 Oct 2019 31 Dec 2019 10-K 23 Mar 2021 2020 FY
Q3 2019 $538,000 $115,000 -$21,000 -15% 01 Jul 2019 30 Sep 2019 10-Q 13 Nov 2020 2020 Q3
Q2 2019 $559,000 $126,000 +$1,000 +0.8% 01 Apr 2019 30 Jun 2019 10-Q 13 Aug 2020 2020 Q2
Q1 2019 $558,000 $185,000 +$163,000 +741% 01 Jan 2019 31 Mar 2019 10-Q 14 May 2020 2020 Q1
Q4 2018 $395,000 $112,000 +$719,000 01 Oct 2018 31 Dec 2018 10-K 13 Mar 2020 2019 FY
Q3 2018 $324,000 $136,000 -$1,131,000 -89% 01 Jul 2018 30 Sep 2018 10-Q 14 Nov 2019 2019 Q3
Q2 2018 $807,000 $125,000 -$1,447,000 -92% 01 Apr 2018 30 Jun 2018 10-Q 14 Aug 2019 2019 Q2
Q1 2018 $2,254,000 $22,000 -$915,000 -98% 01 Jan 2018 31 Mar 2018 10-Q 15 May 2019 2019 Q1
Q4 2017 $3,169,000 $607,000 01 Oct 2017 31 Dec 2017 10-K 22 Mar 2019 2018 FY
Q3 2017 $1,267,000 01 Jul 2017 30 Sep 2017 10-Q 14 Nov 2018 2018 Q3
Q2 2017 $1,572,000 01 Apr 2017 30 Jun 2017 10-Q 14 Aug 2018 2018 Q2
Q1 2017 $937,000 01 Jan 2017 31 Mar 2017 10-Q 15 May 2018 2018 Q1
Q2 2015 $3,521,000 $643,000 -$809,000 -56% 01 Apr 2015 30 Jun 2015 10-Q 06 Aug 2015 2015 Q2
Q1 2015 $4,330,000 $627,000 -$1,057,000 -63% 01 Jan 2015 31 Mar 2015 10-Q 07 May 2015 2015 Q1
Q4 2014 $5,387,000 $951,000 -$609,000 -39% 01 Oct 2014 31 Dec 2014 10-K 05 Mar 2015 2014 FY
Q3 2014 $5,996,000 $1,300,000 +$839,000 +182% 01 Jul 2014 30 Sep 2014 10-Q 05 Nov 2014 2014 Q3
Q2 2014 $5,157,000 $1,452,000 +$933,000 +180% 01 Apr 2014 30 Jun 2014 10-Q 06 Aug 2015 2015 Q2
Q1 2014 $4,224,000 $1,684,000 +$1,320,000 +363% 01 Jan 2014 31 Mar 2014 10-Q 07 May 2015 2015 Q1
Q4 2013 $2,904,000 $1,560,000 +$1,117,000 +252% 01 Oct 2013 31 Dec 2013 10-K 05 Mar 2015 2014 FY
Q3 2013 $1,787,000 $461,000 +$97,000 +27% 01 Jul 2013 30 Sep 2013 10-Q 05 Nov 2014 2014 Q3
Q2 2013 $1,690,000 $519,000 +$285,000 +122% 01 Apr 2013 30 Jun 2013 10-Q 11 Aug 2014 2014 Q2
Q1 2013 $1,405,000 $364,000 -$354,000 -49% 01 Jan 2013 31 Mar 2013 10-Q 06 May 2014 2014 Q1
Q4 2012 $1,759,000 $443,000 01 Oct 2012 31 Dec 2012 10-K 05 Mar 2015 2014 FY
Q3 2012 $364,000 01 Jul 2012 30 Sep 2012 10-Q/A 07 Nov 2013 2013 Q3
Q2 2012 $234,000 01 Apr 2012 30 Jun 2012 10-Q 09 Aug 2013 2013 Q2
Q1 2012 $718,000 01 Jan 2012 31 Mar 2012 10-Q 09 May 2013 2013 Q1

SELLAS Life Sciences Group, Inc. Annual Share-based Payment Arrangement, Expense (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2024 $1,564,000 -$530,000 -25% 01 Jan 2024 31 Dec 2024 10-K 20 Mar 2025 2024 FY
2023 $2,094,000 +$368,000 +21% 01 Jan 2023 31 Dec 2023 10-K 20 Mar 2025 2024 FY
2022 $1,726,000 +$715,000 +71% 01 Jan 2022 31 Dec 2022 10-K 28 Mar 2024 2023 FY
2021 $1,011,000 +$433,000 +75% 01 Jan 2021 31 Dec 2021 10-K 16 Mar 2023 2022 FY
2020 $578,000 +$5,000 +0.87% 01 Jan 2020 31 Dec 2020 10-K 31 Mar 2022 2021 FY
2019 $573,000 +$178,000 +45% 01 Jan 2019 31 Dec 2019 10-K 23 Mar 2021 2020 FY
2018 $395,000 -$2,774,000 -88% 01 Jan 2018 31 Dec 2018 10-K 13 Mar 2020 2019 FY
2017 $3,169,000 +$2,815,000 +795% 01 Jan 2017 31 Dec 2017 10-K 22 Mar 2019 2018 FY
2016 $354,000 01 Jan 2016 31 Dec 2016 10-K 13 Apr 2018 2017 FY
2014 $5,387,000 +$2,483,000 +86% 01 Jan 2014 31 Dec 2014 10-K 05 Mar 2015 2014 FY
2013 $2,904,000 +$1,145,000 +65% 01 Jan 2013 31 Dec 2013 10-K 05 Mar 2015 2014 FY
2012 $1,759,000 -$766,000 -30% 01 Jan 2012 31 Dec 2012 10-K 05 Mar 2015 2014 FY
2011 $2,525,000 01 Jan 2011 31 Dec 2011 10-K 17 Mar 2014 2013 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.